Cellectis Reports Financial Results for First Quarter 2024
• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca
Source: eagletribune.com
Allogeneic Car Development Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Allogeneic Car Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Allogeneic Car Development Programs Today - Breaking & Trending Today
Cellectis Reports Financial Results For First Quarter 2024
. Cellectis announced completion of the additional equity investment of $140M by AstraZeneca . Cash position of $143 million as of March 31
Source: menafn.com
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic...
Source: marketscreener.com
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
• Strategic Collaboration and Investment Agreements signed with AstraZenecaUpdated results of the Phase I BALLI-01 Trial evaluating UCART22 in r/...
Source: businessinsider.com
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2023
First r/r ALL patient dosed in Europe with Cellectis’ UCART22 product candidate manufactured in-houseCellectis implements CLLS52 for the first time in the clinic with Sanofi’s... | May 4, 2023
Source: marketscreener.com